Search is Powered by Google
Cancer / Oncology News

Navaris Medical Lauded For New Technology That Can Detect Breast Cancer Earlier, More Precisely

Main Category: Cancer / Oncology
Also Included In: Women's Health / Gynecology;  Medical Devices
Article Date: 19 Nov 2007 - 2:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

A team of scientists created a new technology intended to detect breast cancer earlier and more precisely through intra-operative 3D imaging to win the 3rd Annual Intel+UC Berkeley Technology Entrepreneurship Challenge (IBTEC) last night. The Navaris Medical entry was judged by a team of venture capitalists from the San Francisco Bay Area. Criteria for the win was the best new technology with the greatest potential for a positive impact on society. Intel awarded the German team $25,000.

In addition, NRG Fuels team of Israel was awarded second place for its biodiesel production from micro algae growth technology. Third place was awarded to a Brazilian team for the vEYE, a navigation system for visually impaired people for greater autonomy. A team from Russia was named "audience favorite" for its battery-free electronics.

"These teams show how rich our global community is in its innovative and pioneering spirit," said William A. Swope, Intel Corporation vice president and general manager, Corporate Affairs Group. "Technology reaches its highest calling when it helps people. These projects have expanded possibilities for people around the world."

The competition was held at the Haas School of Business, in Berkeley, Calif., and hosted 21 teams from 11 countries. The program is designed to showcase global business opportunities that have the greatest potential for a positive impact on society through the deployment of new and truly innovative technologies. Not only does the winning team receive $25,000 and the winning title, but its members will also have direct visibility and interaction with more than 20 leading venture capitalist firms.

Founded in 2005 through a collaboration between UC Berkeley and Intel, IBTEC seeks to support and promote entrepreneurship globally, predominantly in developing countries. This year, business plans included ground-breaking topics such as an optical mouse for secure electronic transactions and a biosensor tool that gives winemakers the ability to make real-time decisions in the tending of their vineyards.

As part of Intel's Higher Education Program, The Intel+UC Berkeley Technology Entrepreneurship Education Program encourages and prepares students everywhere to become tomorrow's technology entrepreneurs. Teams are judged on their ability to make the greatest impact through the deployment of emerging and innovative technology products and services. Judges are selected from Bay Area venture firms with a global focus.

From local schools to global universities, Intel works to help improve the quality of education and drive innovation around the world. Over the past decade alone, Intel has invested more than $1 billion in cash and in-kind contributions to help teachers teach, students learn and universities innovate. To learn more about Intel's commitment to education, visit http://www.intel.com/education.

About Intel

Intel, the world leader in silicon innovation, develops technologies, products and initiatives to continually advance how people work and live. Additional information about Intel is available at http://www.intel.com .

Intel, the Intel logo, Intel Xeon, Intel I/O Acceleration and Intel Higher Education Program are trademarks of Intel Corporation in the United States and other countries.

*Other names and brands may be claimed as the property of others.

http://www.intel.com




Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Schizophrenia

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating Prostate Cancer Symptoms image Treating Prostate Cancer Symptoms

Many men will have advanced prostate cancer without any noticeable symptoms. Treatment for these patients is a bit different than for other patients with prostate cancer. Learn about these differences...

View more videos...